Growth Metrics

Chemours (CC) Cost of Revenue (2016 - 2025)

Chemours has reported Cost of Revenue over the past 12 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Cost of Revenue at $1.2 billion for Q4 2025, up 7.31% from a year ago — trailing twelve months through Dec 2025 was $4.9 billion (up 5.71% YoY), and the annual figure for FY2025 was $4.9 billion, up 5.73%.
  • Cost of Revenue for Q4 2025 was $1.2 billion at Chemours, down from $1.3 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for CC hit a ceiling of $1.4 billion in Q2 2022 and a floor of $1.1 billion in Q1 2024.
  • Median Cost of Revenue over the past 5 years was $1.2 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Cost of Revenue: soared 55.59% in 2021 and later decreased 11.85% in 2023.
  • Chemours' Cost of Revenue stood at $1.2 billion in 2021, then fell by 3.81% to $1.1 billion in 2022, then fell by 2.11% to $1.1 billion in 2023, then dropped by 1.71% to $1.1 billion in 2024, then grew by 7.31% to $1.2 billion in 2025.
  • The last three reported values for Cost of Revenue were $1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025) per Business Quant data.